Tandem Diabetes Care (TNDM) Other Non-Current Liabilities (2013 - 2026)

Tandem Diabetes Care's Other Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $50.4 million for Q1 2026.

• Quarterly Other Non-Current Liabilities rose 36.01% year-over-year to $50.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.4 million (up 36.01% YoY) and the FY2025 annual result came in at $49.7 million, up 53.67% from the prior year.
• Other Non-Current Liabilities was $50.4 million for Q1 2026 at Tandem Diabetes Care, up from $49.7 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $52.4 million in Q3 2025 and bottomed at $17.2 million in Q2 2022.
• A 5-year average of $32.8 million and a median of $32.2 million in 2024 frame the typical range for Other Non-Current Liabilities.
• Peak annual rise in Other Non-Current Liabilities reached 19752.59% in 2022, while the deepest fall reached 38.28% in 2022.
• Tandem Diabetes Care's Other Non-Current Liabilities stood at $23.9 million in 2022, then soared by 33.08% to $31.8 million in 2023, then climbed by 1.69% to $32.4 million in 2024, then surged by 53.67% to $49.7 million in 2025, then increased by 1.35% to $50.4 million in 2026.
• Business Quant data shows TNDM's Other Non-Current Liabilities at $50.4 million in Q1 2026, $49.7 million in Q4 2025, and $52.4 million in Q3 2025.